Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-Mar 2023. Module: US National Library of Medicine maintained module (core metadata concept)
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1276451000124118 | Dose-adjusted etoposide-prednisolone-oncovin-cyclophosphamide-hydroxydaunorubicin (regime/therapy) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | US National Library of Medicine maintained module (core metadata concept) |
| 1276461000124116 | Dose-adjusted etoposide-prednisolone-oncovin-cyclophosphamide-hydroxydaunorubicin | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | US National Library of Medicine maintained module (core metadata concept) |
| 1276471000124111 | Dose-adjusted EPOCH - etoposide-prednisolone-oncovin-cyclophosphamide-hydroxydaunorubicin | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | US National Library of Medicine maintained module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Dose-adjusted etoposide-prednisolone-oncovin-cyclophosphamide-hydroxydaunorubicin (regime/therapy) | Is a | Antineoplastic chemotherapy regimen (regime/therapy) | true | Inferred relationship | Some | ||
| Dose-adjusted etoposide-prednisolone-oncovin-cyclophosphamide-hydroxydaunorubicin (regime/therapy) | Method | Administration - action | true | Inferred relationship | Some | 3 | |
| Dose-adjusted etoposide-prednisolone-oncovin-cyclophosphamide-hydroxydaunorubicin (regime/therapy) | Method | Administration - action | true | Inferred relationship | Some | 4 | |
| Dose-adjusted etoposide-prednisolone-oncovin-cyclophosphamide-hydroxydaunorubicin (regime/therapy) | Method | Administration - action | true | Inferred relationship | Some | 5 | |
| Dose-adjusted etoposide-prednisolone-oncovin-cyclophosphamide-hydroxydaunorubicin (regime/therapy) | Direct substance | Etoposide (substance) | true | Inferred relationship | Some | 3 | |
| Dose-adjusted etoposide-prednisolone-oncovin-cyclophosphamide-hydroxydaunorubicin (regime/therapy) | Direct substance | Doxorubicin hydrochloride | true | Inferred relationship | Some | 4 | |
| Dose-adjusted etoposide-prednisolone-oncovin-cyclophosphamide-hydroxydaunorubicin (regime/therapy) | Direct substance | Prednisolone | true | Inferred relationship | Some | 5 | |
| Dose-adjusted etoposide-prednisolone-oncovin-cyclophosphamide-hydroxydaunorubicin (regime/therapy) | Is a | Immunosuppressant drug therapy | true | Inferred relationship | Some | ||
| Dose-adjusted etoposide-prednisolone-oncovin-cyclophosphamide-hydroxydaunorubicin (regime/therapy) | Is a | Corticosteroid and/or corticosteroid derivative therapy | true | Inferred relationship | Some | ||
| Dose-adjusted etoposide-prednisolone-oncovin-cyclophosphamide-hydroxydaunorubicin (regime/therapy) | Has intent | Therapeutic | true | Inferred relationship | Some | 2 | |
| Dose-adjusted etoposide-prednisolone-oncovin-cyclophosphamide-hydroxydaunorubicin (regime/therapy) | Is a | Antibiotic therapy | false | Inferred relationship | Some | ||
| Dose-adjusted etoposide-prednisolone-oncovin-cyclophosphamide-hydroxydaunorubicin (regime/therapy) | Method | Administration - action | true | Inferred relationship | Some | 1 | |
| Dose-adjusted etoposide-prednisolone-oncovin-cyclophosphamide-hydroxydaunorubicin (regime/therapy) | Direct substance | Cyclophosphamide (substance) | true | Inferred relationship | Some | 1 | |
| Dose-adjusted etoposide-prednisolone-oncovin-cyclophosphamide-hydroxydaunorubicin (regime/therapy) | Is a | Cyclophosphamide therapy (procedure) | true | Inferred relationship | Some | ||
| Dose-adjusted etoposide-prednisolone-oncovin-cyclophosphamide-hydroxydaunorubicin (regime/therapy) | Is a | Anthracycline therapy | true | Inferred relationship | Some | ||
| Dose-adjusted etoposide-prednisolone-oncovin-cyclophosphamide-hydroxydaunorubicin (regime/therapy) | Is a | Administration of mitotic inhibitor (procedure) | true | Inferred relationship | Some | ||
| Dose-adjusted etoposide-prednisolone-oncovin-cyclophosphamide-hydroxydaunorubicin (regime/therapy) | Is a | Hormone therapy | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR